Your session is about to expire
← Back to Search
Behavioural Intervention
Mobile Clinic Services for Women Who Inject Drugs
N/A
Recruiting
Led By Maria Corcorran, MD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will set up a pop-up clinic in a van near areas where women who inject drugs gather in north Seattle. The clinic will offer HIV prevention medication, opioid use disorder medication, and testing for
Who is the study for?
This trial is for women over 18 who inject drugs and are not known to have HIV. Participants must be willing to give informed consent, identify as female, and have a history of drug injection.
What is being tested?
The study tests the effectiveness of a mobile van clinic in increasing the use of HIV prevention medication (PrEP) and treatments for opioid addiction among women who inject drugs. It also evaluates on-site STI testing's impact on treatment completion rates.
What are the potential side effects?
Since this trial involves healthcare services rather than medications, there aren't typical side effects like with drugs. However, participants may experience discomfort or privacy concerns during testing or treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evaluate uptake of PrEP and MOUD
Other study objectives
Assess acceptability of POC STI testing at community-based site
Assess acceptability of pilot community-based care model
Evaluate sustained use of PrEP and MOUD
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Study cohortExperimental Treatment1 Intervention
The investigators will enroll 50 female-identifying people who present to the clinical van for care and follow them for 6 months. The investigators will assess uptake of PrEP and buprenorphine; POC STI testing and treatment completion rates; sustained use of PrEP and buprenorphine at months 3 and 6 (n=50). The investigators will conduct surveys to assess and characterize the acceptability and feasibility of venue-based primary and HIV prevention care among women who inject drugs (WWID).
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,824 Previous Clinical Trials
1,913,300 Total Patients Enrolled
5 Trials studying Syphilis
4,236 Patients Enrolled for Syphilis
National Institute on Drug Abuse (NIDA)NIH
2,595 Previous Clinical Trials
3,328,693 Total Patients Enrolled
3 Trials studying Syphilis
3,201 Patients Enrolled for Syphilis
Maria Corcorran, MD, MPHPrincipal InvestigatorUniversity of Washington